Skip to main content

Forefront Analytics, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1696802 WEST CONSHOHOCKEN, PA

Position in REGN

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$355,414
+$25,826 QoQ
Shares Held
460
+7.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
3.67%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Forefront Analytics, LLC holds $1,546,861 across 10 Biotechnology names. REGN ranks #2 (23.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 REGN
Regeneron Pharmaceuticals, Inc.
This page
460 $355,414

All Filings in REGN

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $355,414 460
2025-12-31 $329,588 427
2025-09-30 $231,655 412
2025-06-30 $257,250 490
2024-12-31 $262,136 368
2024-09-30 $312,218 297
2024-06-30 $344,737 328
2024-03-31 $331,096 344
2023-12-31 $280,173 319
2023-09-30 $241,127 293
2023-06-30 $245,021 341
2023-03-31 $293,335 357
2022-12-31 $221,497 307
2022-09-30 $216,993 315
2022-03-31 $359,685 515
2021-12-31 $247,555 392
2021-09-30 $231,177 382
2021-06-30 $235,703 422
2021-03-31 $238,935 505